Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
488 hedge funds and large institutions have $12B invested in Shockwave Medical, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 150 increasing their positions, 158 reducing their positions, and 57 closing their positions.
111% more first-time investments, than exits
New positions opened: 120 | Existing positions closed: 57
88% more funds holding in top 10
Funds holding in top 10: 8 → 15 (+7)
75% more capital invested
Capital invested by funds: $6.84B → $12B (+$5.15B)
14% more funds holding
Funds holding: 427 → 488 (+61)
5% less repeat investments, than reductions
Existing positions increased: 150 | Existing positions reduced: 158
10% less call options, than puts
Call options by funds: $220M | Put options by funds: $245M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$144M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$70.7M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$64.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$59.4M |
| 5 |
RI
RTW Investments
New York
|
+$54.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$97M |
| 2 |
AC
Armistice Capital
New York
|
-$88.4M |
| 3 |
Morgan Stanley
New York
|
-$87.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$45.9M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$40.8M |
SWAV Hedge Fund Activity: Q1 2024 in Review
488 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q1 2024, worth a combined $12B — up 75% from $6.84B a quarter earlier.
Buyers outnumbered sellers: 120 funds opened new SWAV positions and 57 closed out — a net gain of 63 holders — while 150 added to existing stakes and 158 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $144M. The largest seller was Citadel Advisors, cutting an estimated $97M.
- 488 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q1 2024, up from 427 in Q4 2023.
- Funds reported $12B of Shockwave Medical, Inc. Common Stock stock for Q1 2024, up 75% quarter-over-quarter.
- 120 funds opened new Shockwave Medical, Inc. Common Stock positions in Q1 2024 and 57 closed out, a net change of +63 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q1 2024 was Fidelity Investments, an estimated $144M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q1 2024 was Citadel Advisors, an estimated $97M sold.
Based on aggregated 13F filings for Q1 2024.